Download as PDF February 17, 2026 Related Documents Audio Earnings Webcast Management Commentary PDF 10-K Filing PDF HTML XBRL ZIP HTML SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for…
Download as PDF
February 17, 2026
Related Documents
Audio
Earnings Webcast
Management Commentary
PDF
10-K Filing
PDF
HTML
XBRL
ZIP
HTML
SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026.
Key Financial and Operating Results
|
|
|
|
|
|
|
|
|
Q4 2025 |
|
Q4 2024 |
|
FY 2025 |
|
FY 2024 |
| Net sales |
$226.2 |
|
$213.6 |
|
$925.3 |
|
$854.5 |
| Net (loss) earnings* |
$-1.8 |
|
$4.5 |
|
$10.8 |
|
$42.0 |
| Diluted EPS |
$-0.10 |
|
$0.23 |
|
$0.58 |
|
$2.19 |
| Adjusted diluted EPS(1) |
$0.60 |
|
$0.64 |
|
$1.93 |
|
$2.59 |
| Adjusted EBITDA(2) |
$27.3 |
|
$25.5 |
|
$101.3 |
|
$110.3 |
| USANA Active Customers |
387,000 |
|
454,000 |
|
387,000 |
|
454,000 |
| Hiya Active Monthly Subscribers |
181,700 |
|
N/A |
|
181,700 |
|
N/A |
|
| *Pretax earnings for Q4 2025 totaled $4.0 million with income tax expense of $5.8 million. The adjustment to income taxes during the period, largely as a result of one-time impairment and cost realignment charges, is about $3.1 million greater than what would have been expected using the previously expected 65% tax rate. |
| Net sales, Net (loss) earnings and Adjusted EBITDA figures in millions. |
| Net earnings, EPS and Adjusted EBITDA figures represent amounts attributable to USANA. |
Fiscal Year 2026 Outlook
- Consolidated net sales between $925 million and $1.0 billion, or flat to 8% growth.
- Net earnings between $20.3 million and $26.6 million.
- Diluted EPS between $1.11 and $1.45.
- Adjusted Diluted EPS(1) between $1.95 and $2.29.
- Adjusted EBITDA(2) between $101.3 million and $109.3 million.
Q4 2025 Financial Performance
|
|
|
|
| Consolidated Results |
|
|
|
|
|
Year-Over-Year |
Sequentially |
| Net sales |
$226 million |
+6% * |
+6% * |
| Net (loss) |
-$1.8 million |
N/A |
N/A |
| Diluted EPS |
-$0.10 |
N/A |
N/A |
| Adjusted diluted EPS(1) |
$0.60 |
-6% |
N/A |
| Adjusted EBITDA(2) |
$27.0 million |
+7% |
+98% |
|
| *No meaningful FX impact |
| Net (loss) earnings, EPS and Adjusted EBITDA figures represent amounts attributable to USANA. |
“USANA delivered fourth quarter net sales in line with our preliminary results announced on January 12, 2026,” said Kevin Guest, Chairman and Chief Executive Officer. “We began to see signs of stabilization in active customer counts in our core nutritional business as net sales in this segment increased modestly sequentially, led by growth in key markets including mainland China, the United States and Canada. Meanwhile, our omnichannel brands, Hiya and Rise, posted solid year-over-year growth.”
Fiscal Year 2025 Financial Performance
|
|
|
| Consolidated Results |
|
|
| Net sales |
$925 million |
+8% YOY |
|
|
+9% constant currency |
|
|
-$3 million YOY FX impact |
| Net earnings |
$10.8 million |
-74% |
| Diluted EPS |
$0.58 |
-74% |
| Adjusted diluted EPS(1) |
$1.93 |
-25% |
| Adjusted EBITDA(2) |
$101.3 million |
-8% |
Net earnings, EPS and Adjusted EBITDA figures represent amounts attributable to USANA
Mr. Guest continued, “Fiscal 2025 net sales grew 8%, driven primarily by a full-year contribution from Hiya. Net sales in the core nutritional business declined 8%, reflecting a challenging environment for customer acquisition in key markets. Despite this challenge, we continued to execute our diversification strategy towards an omnichannel model. That strategy is designed to support growth beyond our core nutritional business as well as to restructure and modernize our business for today’s evolving marketplace. Rise Wellness generated strong momentum with sales tripling, albeit off a small base in 2024, as distribution expanded into key retail outlets. The business is on pace for a robust year of sales growth supported by the launch of Protein Pop at a large club retailer in the first quarter. Net sales outside of our core nutritional business represented 16% of consolidated net sales in 2025, up from approximately 1% in 2024. We expect this share to increase to more than 20% of consolidated net sales in fiscal 2026.”
Q4 2025 Core Nutritional Business Regional Results:
|
|
|
|
|
| Asia Pacific Region |
|
|
|
|
|
|
|
Year-Over-Year |
Year-over-Year (Constant Currency) |
| Net sales |
|
$151 million |
-10% |
No material FX impact |
| USANA Active Customers |
|
306,000 |
-15% |
N/A |
|
|
|
|
|
|
| Asia Pacific Sub-Regions |
|
|
|
|
|
|
|
|
Year-Over-Year |
Year-over-Year (Constant Currency) |
Sequentially |
| Greater China |
Net sales |
$100 million |
-11% |
No material FX impact |
+8% |
| USANA Active |
208,000 |
-15% |
N/A |
-1% |
|
| Customers |
|
|
|
|
|
| North Asia |
Net sales |
$17 million |
+2% |
+5% |
-5% |
| USANA Active |
35,000 |
-8% |
N/A |
-5% |
|
| Customers |
|
|
|
|
|
| Southeast Asia Pacific |
Net sales |
$34 million |
-10% |
-12% |
+17% |
| USANA Active |
63,000 |
-18% |
N/A |
+3% |
|
| Customers |
|
|
|
|
|
|
|
|
|
|
| Americas and Europe Region |
|
|
|
|
|
|
|
Year-Over-Year |
Year-over-Year (Constant Currency) |
| Net sales* |
|
$45 million |
+1% |
Flat |
| USANA Active Customers |
|
81,000 |
-13% |
N/A |
*Includes $4.5 million of ‘Other’
Q4 2025 Hiya Direct to Consumer Results:
|
|
| Hiya |
|
| Net sales |
$30 million |
| Active Monthly Subscribers |
181,700 |
Balance Sheet
The Company ended the year with $158 million in cash and cash equivalents and $14 million of debt. As of January 3, 2026, inventory totaled $107 million, an increase of approximately $35 million, or 48% compared to balances at year-end 2024. This increase was primarily driven by the addition of inventory to support the rapid growth of the Rise Wellness brands and a planned ramp up of raw materials inventory as part of bringing the production of Hiya products in-house. Importantly, our balance sheet remains in a strong net cash position, providing us with the financial flexibility to continue executing our strategic priorities.
The Company repurchased 927,000 shares in fiscal 2025 for an investment of $28 million. As of January 3, 2026, the Company had approximately $34 million remaining under the current share repurchase authorization.
Fiscal Year 2026 Outlook
Mr. Guest continued, “We are leveraging our strong foundation in the nutrition business and expanding beyond our legacy channel to connect with a greater number of health-conscious consumers worldwide. We see an extraordinary opportunity in a growing global health and wellness market to strengthen our brand relevance through an omnichannel approach. By deepening consumer engagement, empowering our Brand Partners, and executing with discipline, we believe we can accelerate profitable growth, extend our competitive advantages, and deliver sustainable long-term value for our shareholders.
“We also remain focused on product innovation and development to meet the evolving nutritional needs of our consumers. We introduced several new products and upgraded several top-selling products in 2025, and plan to launch these products across all markets in 2026. Furthermore, we intend to accelerate our technology initiatives to modernize our core systems and fundamentally improve how customers experience our brand while driving future cost efficiencies across our IT infrastructure. We are planning to strategically leverage best-in-class third-party platforms to move faster, scale smarter, and deliver capabilities to enable future growth and improve customer interactions. Our focus is on deploying the most effective technologies and partnering with industry-leading providers to create real value for customers and a durable advantage for our business. As I have recently resumed the CEO role, this plan is still being finalized and is not reflected in our fiscal 2026 guidance, and we will provide an update upon its full formalization and approval.
“Hiya is expected to deliver solid top line growth in 2026, driven by continued strength in its core direct-to-consumer business and early expansion into new distribution channels and international markets. Moreover, we have begun manufacturing Hiya products in‑house, a strategic shift that we expect will generate savings in the back half of 2026 as efficiencies scale and integration benefits materialize.
“Building on the strong momentum over the last several quarters, Rise Wellness is expected to accelerate net sales growth in 2026. Notably, Rise Wellness consists of two brands, Rise Bar and Protein Pop – a new product line we launched mid-year 2025. While Rise Bar sales were driven by entrance into a large club retailer in 2025, Protein Pop went from concept to launch on the shelves of a key retailer over a few short months. Much of the growth in Rise Wellness is expected to be driven by expansion of Protein Pop into the club retail channel.”
The Company is providing its outlook for fiscal year 2026, as detailed in the table below:
|
|
| Fiscal Year 2026 Outlook |
|
|
Range |
| Core nutritional business net sales |
$720 to $765 million* |
| Hiya net sales |
$140 to $155 million |
| Rise Wellness net sales |
$65 to $80 million |
| Consolidated net sales |
$925 million to $1.0 billion |
|
|
| Net earnings |
$20.3 million to $26.6 million |
| Diluted EPS |
$1.11 to $1.45 |
| Adjusted diluted EPS(1) |
$1.95 to $2.29 |
| Adjusted EBITDA(2) |
$101.3 million to $109.3 million |
*Reflects an expected favorable currency exchange rate impact of approximately $19 million, or 3% on net sales and one less week of operations compared to fiscal year 2025 which was a 53-week year.
Doug Hekking, Chief Financial Officer, said, “Fourth‑quarter and full‑year net sales came in modestly ahead of our expectations, although reported GAAP results reflected the impact of two notable items. During the quarter, we recorded a non‑cash impairment charge of $7.0 million of goodwill and intangibles in one of our reporting units, that resulted from a sustained decline in our share price and resulting market capitalization. We also incurred a $6.5 million charge related to our previously communicated cost realignment initiatives, primarily aligning headcount with sales levels. As a result of the impact of the impairment and cost realignment initiatives, the annualized effective income tax rate in the fourth quarter increased from 65.0% to 72.4%. The adjustment was approximately $3.1 million greater than what would have been expected using the previously expected 65.0% tax rate. The fourth quarter also included incremental net sales of approximately $11.2 million attributable to the additional week of operations in the core nutritional business.
“Looking ahead, we are projecting fiscal 2026 consolidated net sales in a range of flat to 8% growth. Our outlook for the core nutritional business anticipates an approximately 0-5% decline in fiscal 2026, but we remain confident that the actions underway will stabilize the business over time and ultimately position it to return to sustainable growth. Hiya is anticipated to grow net sales 6% to 17%, while Rise Wellness is expected to continue to deliver accelerated net sales growth.
“We are making meaningful investments in inventory, working capital, and capital expenditures, while simultaneously deploying incremental operational resources to support the growth of Hiya and Rise Wellness including building brand awareness. These actions are designed to strengthen the scalability of both platforms and position the brands for sustained, long-term value creation.”
|
|
|
| ____________________ |
|
|
| (1) |
|
Adjusted Diluted EPS is a non-GAAP financial measure. The Company excludes cost realignment expenses, impairment expense, gain on sale of assets, and acquisition-related costs, such as business transaction costs, integration expense and amortization expense from acquisition related intangible assets in calculating Adjusted Diluted EPS. Please refer to “Non-GAAP Financial Measures” and “Reconciliation of Diluted (Loss) Earnings Per Share (GAAP) to Adjusted Diluted EPS (Non-GAAP)” in this press release for an explanation and reconciliation of this non-GAAP financial measure. |
| (2) |
|
Adjusted EBITDA is a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” and “Reconciliation of Net (Loss) Earnings (GAAP) to Adjusted EBITDA (Non-GAAP)” in this press release for an explanation and reconciliation of this non-GAAP financial measure. |
Non-GAAP Financial Measures
This press release contains the non-GAAP financial measures Adjusted EBITDA and Adjusted diluted EPS. Adjusted EBITDA is a Non-GAAP financial measure of earnings before interest, taxes, depreciation, and amortization that also excludes certain adjustments as indicated below in the reconciliation from net earnings. Adjusted diluted EPS is a Non-GAAP financial measure of diluted earnings per share that excludes certain adjustments as indicated below in the reconciliation from diluted EPS.
Adjusted EBITDA (non-GAAP) is net earnings (loss) (its most directly comparable GAAP financial measure) adjusted for interest expense, net, (benefit from) provision for income taxes, depreciation and amortization, non-cash share-based compensation, transaction-related expenses and integration costs for the Hiya acquisition, cost realignment expenses, impairment expense, and gain on sale of assets. Adjusted EBITDA attributable to USANA (non-GAAP) is Adjusted EBITDA (non-GAAP) further adjusted to exclude the Adjusted EBITDA attributable to non-controlling interest related to Hiya.
Adjusted diluted EPS (non-GAAP) is diluted earnings (loss) per share (its most directly comparable GAAP financial measure) adjusted for amortization of intangible assets, transaction-related expenses, integration costs related to the Hiya acquisition, cost realignment expenses, impairment expense, and gain on sale of assets.
Management believes that Adjusted EBITDA (non-GAAP), Adjusted EBITDA attributable to USANA (non-GAAP), and Adjusted diluted EPS (non-GAAP), along with GAAP measures used by management, most appropriately reflect how the Company measures the business internally.
The Company prepares its financial statements using U.S. generally accepted accounting principles (“GAAP”) and investors should not directly compare with or infer relationship from any of the Company’s operating results presented in accordance with GAAP to Adjusted EBITDA and Adjusted diluted EPS. Non-GAAP financial measures have limitations in their usefulness to investors because they have no standardized meaning prescribed by GAAP and are not prepared under any comprehensive set of accounting rules or principles. In addition, other companies, including companies in our industry, may calculate similarly titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of non-GAAP financial information as a tool for comparison. As a result, the non-GAAP financial information is presented for supplemental informational purposes only and should not be considered in isolation from, or as a substitute for financial information presented in accordance with GAAP.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reconciliation of Net (Loss) Earnings (GAAP) to Adjusted EBITDA (non-GAAP) (in thousands) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended |
|
|
|
|
|
|
|
Year Ended |
|
|
|
|
|
|
|
|
January 3, 2026 |
|
|
|
December 28, 2024 |
|
|
|
January 3, 2026 |
|
|
|
December 28, 2024 |
|
|
| Net (loss) earnings attributable to USANA (GAAP) |
|
$ |
(1,775 |
) |
|
$ |
4,454 |
|
|
$ |
10,760 |
|
|
$ |
42,030 |
|
| Net earnings attributable to noncontrolling interest |
|
|
180 |
|
|
|
30 |
|
|
|
717 |
|
|
|
30 |
|
| Net (loss) earnings |
|
$ |
(1,595 |
) |
|
$ |
4,484 |
|
|
$ |
11,477 |
|
|
$ |
42,060 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Income taxes |
|
$ |
5,772 |
|
|
$ |
5,945 |
|
|
$ |
30,050 |
|
|
$ |
34,291 |
|
| Interest (income) expense |
|
|
(372 |
) |
|
|
(2,609 |
) |
|
|
(1,573 |
) |
|
|
(11,038 |
) |
| Depreciation and amortization |
|
|
5,488 |
|
|
|
5,590 |
|
|
|
21,538 |
|
|
|
21,935 |
|
| Amortization of intangible assets - Hiya |
|
|
4,798 |
|
|
|
294 |
|
|
|
18,164 |
|
|
|
294 |
|
| Earnings before interest, taxes, depreciation, and amortization (EBITDA) |
|
$ |
14,091 |
|
|
$ |
13,704 |
|
|
$ |
79,656 |
|
|
$ |
87,542 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Add EBITDA adjustments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Non-cash share-based compensation |
|
|
3,750 |
|
|
|
3,613 |
|
|
|
13,828 |
|
|
|
14,558 |
|
| Transaction, integration and transition costs - Hiya |
|
|
443 |
|
|
|
8,243 |
|
|
|
1,314 |
|
|
|
8,243 |
|
| Inventory step-up - Hiya |
|
|
— |
|
|
|
38 |
|
|
|
1,126 |
|
|
|
38 |
|
| Cost realignment |
|
|
6,463 |
|
|
|
— |
|
|
|
6,463 |
|
|
|
— |
|
| Impairment |
|
|
6,967 |
|
|
|
— |
|
|
|
6,967 |
|
|
|
— |
|
| Gain on disposal of assets |
|
|
(3,240 |
) |
|
|
— |
|
|
|
(3,240 |
) |
|
|
— |
|
| Consolidated adjusted EBITDA |
|
|
28,474 |
|
|
|
25,598 |
|
|
|
106,114 |
|
|
|
110,381 |
|
| Less: Adjusted EBITDA attributable to noncontrolling interest |
|
|
(1,195 |
) |
|
|
(101 |
) |
|
|
(4,799 |
) |
|
|
(101 |
) |
| Adjusted EBITDA attributable to USANA |
|
$ |
27,279 |
|
|
$ |
25,497 |
|
|
$ |
101,315 |
|
|
$ |
110,280 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reconciliation of Diluted (Loss) Earnings Per Share (GAAP) to Adjusted Diluted Earnings Per Share (non-GAAP) (in thousands, except per share data) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended |
|
|
|
|
|
|
|
Year Ended |
|
|
|
|
|
|
|
|
January 3, 2026 |
|
|
|
December 28, 2024 |
|
|
|
January 3, 2026 |
|
|
|
December 28, 2024 |
|
|
| Net (loss) earnings attributable to USANA (GAAP) |
|
$ |
(1,775 |
) |
|
$ |
4,454 |
|
|
$ |
10,760 |
|
|
$ |
42,030 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Loss) earnings per common share - Diluted (GAAP) |
|
$ |
(0.10 |
) |
|
$ |
0.23 |
|
|
$ |
0.58 |
|
|
$ |
2.19 |
|
| Weighted Average common shares outstanding - Diluted |
|
|
18,302 |
|
|
|
19,104 |
|
|
|
18,574 |
|
|
|
19,162 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Adjustment to net (loss) earnings: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Transaction, integration and transition costs - Hiya |
|
$ |
443 |
|
|
$ |
8,243 |
|
|
$ |
1,314 |
|
|
$ |
8,243 |
|
| Inventory step-up - Hiya |
|
|
— |
|
|
|
38 |
|
|
|
1,126 |
|
|
|
38 |
|
| Cost realignment |
|
|
6,463 |
|
|
|
— |
|
|
|
6,463 |
|
|
|
— |
|
| Impairment |
|
|
6,967 |
|
|
|
— |
|
|
|
6,967 |
|
|
|
— |
|
| Gain on disposal of assets |
|
|
(3,240 |
) |
|
|
— |
|
|
|
(3,240 |
) |
|
|
— |
|
| Amortization of intangible assets - Hiya |
|
|
4,798 |
|
|
|
294 |
|
|
|
18,164 |
|
|
|
294 |
|
| Adjustments to net (loss) earnings attributable to noncontrolling interest |
|
|
(1,015 |
) |
|
|
(70 |
) |
|
|
(4,081 |
) |
|
|
(70 |
) |
| Income tax effect of adjustments to net earnings (loss) |
|
|
(1,658 |
) |
|
|
(823 |
) |
|
|
(1,662 |
) |
|
|
(823 |
) |
| Adjusted net earnings attributable to USANA |
|
$ |
10,983 |
|
|
$ |
12,136 |
|
|
$ |
35,811 |
|
|
$ |
49,712 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Adjusted earnings per common share - Diluted |
|
$ |
0.60 |
|
|
$ |
0.64 |
|
|
$ |
1.93 |
|
|
$ |
2.59 |
|
| Weighted average common shares outstanding - Diluted |
|
|
18,302 |
|
|
|
19,104 |
|
|
|
18,574 |
|
|
|
19,162 |
|
Management Commentary Document and Conference Call